Physician profile
Frank S Coletta
NPI 1952421885
$30,067.48
in general payments reported to CMS, 2019-2025
55 companies · $4,780 in 2025
The $4,780 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,071 · 2020: $3,826 · 2021: $3,165 · 2022: $4,475 · 2023: $4,357 · 2024: $5,392 · 2025: $4,780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Long Term Medical Supply Or Device Loan: $3,190 · Education: $464 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,626.05 |
| Long Term Medical Supply Or Device Loan | $3,190.41 |
| Education | $463.81 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $5,286.24 | 2019-2025 | (8269) Dreamstation Cpap, Dreamstation Cpap, Vest Therapy Und |
| Astrazeneca Pharmaceuticals Lp | $4,627.31 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $4,610.11 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,746.89 | 2019-2025 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Jazz Pharmaceuticals INC. | $1,562.15 | 2019-2025 | Xywav |
| Harmony Biosciences LLC | $1,410.09 | 2020-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $738.74 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $636.16 | 2019-2024 | Yupelri |
| Genzyme Corporation | $574.68 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $529.63 | 2019-2025 | Opsumit, Uptravi |
| Fisher & Paykel Healthcare INC | $446.95 | 2019-2025 | Fisher & Paykel Healthcare |
| Amgen INC. | $414.49 | 2019-2025 | Tezspire |
| Grifols USA, LLC | $380.85 | 2019-2025 | Prolastin-C Liquid |
| Chiesi USA, INC. | $363.34 | 2019-2023 | Cleviprex |
| Mallinckrodt Hospital Products INC. | $335.82 | 2022-2025 | Acthar, Terlivaz |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $276.71 | 2019-2025 | |
| Vapotherm INC | $269.85 | 2019-2023 | Vapotherm |
| Janssen Pharmaceuticals, INC | $254.06 | 2019-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $250.49 | 2020-2025 | Hyqvia |
| Electromed, INC. | $250.26 | 2019-2025 | Smartvest |
| Regeneron Pharmaceuticals, INC. | $231.82 | 2019-2025 | Dupixent |
| Baxter Healthcare | $220.38 | 2019-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Inari Medical, INC. | $212.22 | 2019-2022 | |
| Verona Pharma, INC. | $210.82 | 2025 | Ohtuvayre |
| Olympus America INC. | $185.69 | 2019-2022 | |
| Shionogi INC | $170.67 | 2021-2025 | Fetroja |
| Idorsia Pharmaceuticals US INC | $167.98 | 2022-2023 | Quviviq |
| Neurocrine Biosciences, INC. | $135.72 | 2023 | Ingrezza |
| Merck Sharp & Dohme LLC | $127.85 | 2021-2025 | Capvaxive, Zerbaxa |
| Insmed, INC. | $125.39 | 2024-2025 | Arikayce, Brinsupri |
| Advanced Respiratory, INC | $124.77 | 2019-2021 | |
| Inspire Medical Systems, INC. | $113.65 | 2024 | Inspire |
| Zoll Respicardia, INC. | $106.37 | 2024-2025 | Remede System |
| Covidien Lp | $97.11 | 2019 | |
| Genentech USA, INC. | $75.76 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $73.27 | 2019 | |
| Inogen, INC. | $71.37 | 2023-2024 | Inogen At Home Stationary Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Teva Pharmaceuticals USA, INC. | $70.56 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $61.41 | 2025 | Purified Cortrophin Gel |
| Itamar Medical INC | $56.05 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $45.72 | 2019-2021 | |
| Abbvie INC. | $45.33 | 2022-2023 | Teflaro |
| Gilead Sciences, INC. | $43.90 | 2021 | |
| Arbor Pharmaceuticals, INC. | $42.63 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $36.91 | 2019 | |
| 3b Medical, INC. | $35.83 | 2024-2025 | Luna |
| Phadia US INC. | $34.48 | 2022 | |
| Coaptech, INC. | $31.73 | 2022 | |
| Eisai INC. | $24.97 | 2025 | |
| Lilly USA, LLC | $23.88 | 2025 | Zepbound |
| Paratek Pharmaceuticals, INC. | $23.01 | 2021 | |
| Viatris Specialty LLC | $20.90 | 2025 | Yupelri |
| United Therapeutics Corporation | $20.51 | 2024 | Tyvaso |
| Allergan, INC. | $18.85 | 2019 | |
| Circassia INC. | $15.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Coletta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.